Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

7 Apr 2009

Abstract excerpt

Multiple genes and their variants that lend susceptibility to many diseases will play a major role in clinical routine. Genetics-based cost reduction strategies in diagnostic processes are important in the setting of multiple susceptibility genes for a single disease. Head and neck paraganglioma (HNP) is caused by germline mutations of at least three succinate dehydrogenase subunit genes (SDHx). Mutation analysis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Hormonal Regulation and Hypertension
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19351833
DOI: 10.1158/0008-5472.can-08-4057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-OutPMID 19351833Read ↗

Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.Semantic proximity Read ↗

Familial paraganglioma syndrome: applying genetic screening in otolaryngology.Semantic proximity Read ↗

Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.Semantic proximity Read ↗

Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.Semantic proximity Read ↗

Outcomes of SDHB Pathogenic Variant Carriers.Semantic proximity Read ↗

The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with ParagangliomasSemantic proximity Read ↗

SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma.Semantic proximity Read ↗

When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?Semantic proximity Read ↗

Succinate dehydrogenase mutations in head and neck paragangliomas: A systematic review and meta-analysis of individual patients' data.Semantic proximity Read ↗

Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriersSemantic proximity Read ↗

Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma–paragangliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.